Back to search
Adult-Onset Still Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adult-Onset Still Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Adult-Onset Still Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 (arumakimig) in pediatric and adult participants wi…
This study aims to assess and characterize the treatment patterns, and long-term clinical outcomes and demographic characteristics of patients diagnosed with Fa…
Background: Inflammatory conditions can cause symptoms like fevers, arthritis, and rash. Systemic juvenile idiopathic arthritis (sJIA) is one of these conditio…
The purpose of this study is to compare the efficacy and safety of firsekibart versus anakinra in patients with AOSD.
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Adult Onset Still Disease (AOSD) and Systemic onset Juvenile Idiopathic Arthritis (SoJIA) are two rare multifactorial diseases associated with systemic inflamma…
This study was designed to evaluate the efficacy and safety of canakinumab administered subcutaneously every 4 weeks for at least 48 weeks in Japanese patients…
Assessment of macrophage activation syndrome in Still's disease: retrospective chart analysis of patient history, symptom resolution and treatment characterist…